Year 2014 Number of articles 27 Title of study. Journal. Authors
(alphabetic order)
CPE authors Research area
1
Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6- acetylmorphine and reduction of analytes. Drug testing and analysis.
Andersson M,
Stephanson N, Ohman I, Terzuoli T, Lindh JD, Beck O.
Andersson M, Ohman I.
CNS and drugs.
2
Risks of malignant and non- malignant tumours in tall women treated with high- dose oestrogen during adolescence. Hormone research in paediatrics.
Benyi E, Kieler H, Linder M, Ritzén M, Carlstedt- Duke J, Tuvemo T, Westphal O, Sävendahl L.
Kieler H, Linder M. Reproductive
pharmacoepidemiology.
3
Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.
Obstetrics and gynecology.
Bergendal A, Persson I, Odeberg J, Sundström A, Holmström M, Schulman S, Björgell O, Kieler H.
Bergendal A,
Sundström A, Kieler H.
Reproductive
pharmacoepidemiology.
4
Factors associated with pregabalin dispensing at higher than the approved maximum dose. European journal of clinical
pharmacology.
Boden R, Wettermark B, Brandt L, Kieler H.
Boden R, Wettermark B, Brandt L, Kieler H.
CNS and drugs.
5
Birth outcomes in women with inflammatory bowel disease:
effects of disease activity and drug exposure. Inflammatory bowel diseases.
Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H.
Broms G, Granath F, Linder M, Kieler H.
Reproductive
pharmacoepidemiology.
6
Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism.
Thrombosis research.
Bruzelius M, Strawbridge RJ, Trégouët DA, Wiggins KL, Gertow K, Sabater- Lleal M, Öhrvik J, Bergendal A, Silveira A, Sundström A, Kieler H, Syvänen AC, Smith NL, Morange PE, Odeberg J, Hamsten A.
Bergendal A,
Sundström A, Kieler H.
Cardiovascular diseases and drugs.
7
Family history of
cardiovascular disease and influence on statin therapy persistence. European journal of clinical pharmacology.
Citarella A, Kieler H, Sundström A, Linder M, Wettermark B, Berglind IA, Andersen M.
Citarella A, Kieler H, Sundström A, Linder M, Wettermark B, Berglind IA, Andersen M.
Cardiovascular diseases and drugs.
8
Factors associated with concordance between parental-reported use and dispensed asthma drugs in adolescents: findings from the BAMSE birth cohort.
Pharmacoepidemiology and drug safety.
Dahlen E, Almqvist C, Bergstrom A, Wettermark B, Kull I.
Dahlen E, Wettermark B.
Chronic diseases and drugs.
9
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures:
findings and future implications. Frontiers in pharmacology.
Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez- Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Fürst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahović- Palčevski VV, Markovic-
Wettermark B. -
Pekovic V, Vončina L, Malinowska K, Zara C, Gustafsson LL.
10
Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia.
Pediatric pulmonology.
Eriksson L, Haglund B, Odlind V, Altman M, Kieler H.
Haglund B, Kieler H. Reproductive
pharmacoepidemiology.
11
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores:
experience from the
Stockholm region. European journal of clinical
pharmacology.
Forslund T, Wettermark B, Wandell P, von Euler M, Hasselstrom J, Hjemdahl P.
Wettermark B. Cardiovascular diseases and drugs.
12
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics. Breast cancer research and treatment.
Hajiebrahimi M,
Cnattingius S, Lambe M, Hsieh CC, Ahlgren J, Adolfsson J, Bahmanyar S.
Hajiebrahimi MH, Bahmanyar S.
Reproductive
pharmacoepidemiology.
13
The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients. Blood pressure.
Hasselström J, Zarrinkoub R, Holmquist C, Hjerpe P, Ljungman C, Qvarnström M, Wettermark B, Manhem K, Kahan T, Bengtsson Boström K.
Qvarnström M, Wettermark B.
Cardiovascular diseases and drugs.
14
Maternal hypothyroidism in early pregnancy and infant structural congenital malformations. Journal of thyroid research.
Kallen B, Wikner BN. Wikner BN. Reproductive
pharmacoepidemiology.
15
Drug treatment in patients with newly diagnosed
unprovoked seizures/epilepsy.
Epilepsy research.
Karlsson L, Wettermark B, Tomson T.
Wettermark B. CNS and drugs.
16
Risk factors for recurrent venous thromboembolism in young and middle-aged women. Thrombosis research.
Ljungqvist M, Sonnevi K, Bergendal A, Holmstrom M, Kieler H, Larfars G.
Bergendal A, Kieler H. Reproductive
pharmacoepidemiology.
17
Cruciate ligament
reconstruction and risk of knee osteoarthritis: the association between cruciate ligament injury and post- traumatic osteoarthritis: a population based nationwide study in Sweden, 1987-2009.
PloS one.
Nordenvall R, Bahmanyar S, Adami J, Mattila VM, Fellander-Tsai L.
Bahmanyar S. Chronic diseases and drugs.
18
Patients' concern about their medicine after a generic switch: a combined cross- sectional questionnaire and register study.
Pharmacoepidemiology and drug safety.
Rathe J, Sondergaard J, Jarbol DE, Hallas J, Andersen M.
Andersen M. -*
19
Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study. European journal of neurology.
Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S.
Bahmanyar S. Chronic diseases and drugs.
Cardiovascular diseases and drugs.
20
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment.
Rydberg DM, Holm L, Mejyr S, Loikas D, Schenck-Gustafsson K,
Loikas D, Wettermark B.
Cardiovascular diseases and drugs.
European journal of clinical pharmacology.
von Euler M, Wettermark B, Malmström RE.
The influence of comorbidity on mortality in ovarian cancer patients. Gynecologic
oncology.
Stalberg K, Svensson T, Lonn S, Kieler H.
Svensson T, Kieler H. Reproductive
pharmacoepidemiology
21
[30 years with isotretinoin.
"Miracle medicine" against acne with many side effects].
Lakartidningen.
Sundström A. Sundström A. -
22
Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome.
European heart journal.
Varenhorst C, Jensevik K, Jernberg T, Sundström A, Hasvold P, Held C, Lagerqvist B, James S.
Sundström A. Cardiovascular diseases and drugs.
23
Utilization of triptans in Sweden; analyses of over the counter and prescription sales.
Pharmacoepidemiology and drug safety.
von Euler M, Keshani S, Baatz K, Wettermark B.
Wettermark B. -
24
Zonisamide:
pharmacokinetics, efficacy, and adverse events in children with epilepsy.
Neuropediatrics.
Wallander KM, Ohman I, Dahlin M.
Ohman I. Chronic diseases and drugs.
25
Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment.
Wettermark B, Brandt L, Kieler H, Boden R.
Wettermark B, Brandt L, Kieler H, Boden R.
CNS and drugs.
26
Opioid-related mortality and filled prescriptions for buprenorphine and
methadone. Drug and alcohol review.
Wikner BN, Ohman I, Selden T, Druid H, Brandt L, Kieler H.
Wikner BN, Ohman I, Brandt L, Kieler H.
CNS and drugs.
27
Antibiotics in fetal and early life and subsequent childhood asthma: nationwide
population based study with sibling analysis. BMJ (Clinical research ed).
Örtqvist AK, Lundholm C, Kieler H, Ludvigsson JF, Fall T, Ye W, Almqvist C.
Helle Kieler. Reproductive
pharmacoepidemiology.
Chronic diseases and drugs.
